✦ LIBER ✦

992 GENETIC CORRECTION OF PSA LEVELS AND PROSTATE CANCER RISK MARKERS IMPROVE POSITIVE PREDICTIVE VALUE OF THE PSA TEST

✍ Scribed by Gudmundsson, Julius; Gulcher, Jeff; Besenbacher, Soren; Sulem, Patrick; Gudbjartsson, Daniel; Olafsson, Isleifur; Arinbjarnarson, Sturla; Agnarsson, Bjarni; Benediktsdottir, Kristrun; Isaksson, Helgi; Bjornsdottir, Unnur; Eyjolfsson, Gudmundur; Donovan, Jenny; Hamdy, Freddie; Catalona, William; Geirsson, Gudmundur; Einarsson, Gudmundur; Barkardottir, Rosa; Jonsson, Eirikur; Neal, David; Thorsteinsdottir, Unnur; Rafnar, Thorunn; Stefansson, Kari

Book ID: 121925134
Publisher: Lippincott Williams and Wilkins
Year: 2011
Tongue: English
Weight: 42 KB
Volume: 185
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2011.02.1024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IGF-II Serum Levels Increase Discriminat

IGF-II Serum Levels Increase Discrimination Between Benign Prostatic Hyperplasia and Prostate Cancer and Improve the Predictive Value of PSA in Clinical Staging

✍ Lutz Trojan; Christian Bode; Christel Weiss; Doris Mayer; Rainer Grobholz; Peter 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Combination of the preoperative PSA leve

Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer

✍ Anthony V D’Amico; Richard Whittington; S.Bruce Malkowicz; Yue Hui Wu; Ming-Hui 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 134 KB

603Insulin-like growth factor II (IGF-II

603Insulin-like growth factor II (IGF-II) serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging

✍ L. Trojan; C. Bode; C. Weiss; D. Mayer; R. Grobholz; P. Alken; M. Michel 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 179 KB

C47 HEAD TO HEAD COMPARISON OF THE URINA

C47 HEAD TO HEAD COMPARISON OF THE URINARY MARKER PCA3 AND PSA VELOCITY AS RISK FACTORS FOR PROSTATE CANCER PREDICTION IN PATIENTS UNDERGOING REPEAT PROSTATE BIOPSY

✍ M. Auprich; L. Budäus; F.K. Chun; F. Luger; St. Gutschi; G. Gallè; S. Mannweiler 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 591 KB

Multiparametric magnetic resonance imagi

Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy

✍ Alessandro Sciarra; Valeria Panebianco; Susanna Cattarino; Gian Maria Busetto; E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Serum Testosterone: a Potentially Adjunc

Serum Testosterone: a Potentially Adjunct Screening Test for the Assessment of the Risk for Prostate Cancer among Men with Modestly Elevated PSA Values (≥3.0 and <10.0 ng/ml)

✍ Dimitrios Karamanolakis; Theocharis Lambou; John Bogdanos; Constantine Milathian 📂 Article 📅 2009 🏛 Dougmar Publishing Group, Inc. 🌐 English ⚖ 91 KB